top of page

Vedanta Biosciences founder and CEO Bernat Olle shares an expert take on microbiome drug development

  • Oct 3, 2024
  • 1 min read

He describes how Vedanta is isolating specific bacterial strains and using them as a defined composition for its medicines, and why he thinks that is important. Plus, lead programs against C. diff and IBD, and where he sees the broader utility for microbiome therapeutics in the future.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page